Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zevra Therapeutics Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Total Equity
$32.5m
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$70.2B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17.1B
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$44.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Equity
$14.2B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
-2%

See Also

What is Zevra Therapeutics Inc's Total Equity?
Total Equity
32.5m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Total Equity amounts to 32.5m USD.

What is Zevra Therapeutics Inc's Total Equity growth rate?
Total Equity CAGR 3Y
-37%

Over the last year, the Total Equity growth was -53%. The average annual Total Equity growth rates for Zevra Therapeutics Inc have been -37% over the past three years .

Back to Top